[Pharmacology of novel, fast-acting, non-monoaminergic antidepressants]
{{output}}
For decades, the molecular target of drug therapy in the treatment of major depression has been the monoamine system, primarily the serotonin transporter (SERT) and the norepinephrine transporter (NAT). Newer antidepressants have a better side effect profile t... ...
